Back
Jul 24, 2003
At the Council on Foreign Relations roundtable on “Current Negotiations on Agricultural Biotechnology,” today in New York City, American Soybean Association (ASA) Chairman Dwain Ford, a soybean grower from Kinmundy, Ill., said it is imperative that we not go back to a time decades ago when politicians and government restricted trade based on populist opinions.
“Efforts to stigmatize and restrict trade in agricultural biotechnology crops that have been approved by regulators and determined to be even safer than conventional crops gives rise to the question of whether agricultural innovators will be allowed to improve the food products they export to consumers around the world,” Ford said.
According to Ford, a readily available example of this type of unwarranted government restriction is the European Union’s (EU) adoption this week of traceability and labeling regulations for biotech food and feed products. These regulations will require that all food products containing more than 0.9 percent biotech ingredients carry a label, even though the biotech ingredients have been approved by EU regulatory authorities and determined to be safe for food, feed, and the environment. Additionally, all food products containing biotech ingredients must be elaborately traced from farm to fork with records kept for five years, a costly and trade-limiting requirement not being imposed on foods that don’t contain biotech ingredients.
“By bowing to populist pressure, the European Union is making it possible for anti-ag biotech activists to drive biotech products off the shelves, and will ultimately lead to activist pressure for over-regulation of other product advancements,” Ford said. “Despite clear and wide-ranging scientific proof that biotech crops are even safer and more environmentally friendly than conventional crops, the EU has taken action that will deny farmers in the U.S. and elsewhere, who adopt new technologies, access to markets in Europe. To make matters worse, the EU is attempting to ‘export’ its restrictive approach to agricultural innovation to the rest of the world.”
A look at history shows that worldwide protectionist trade restrictions during the 1920s led to global economic hardships in the 1930s. Learning from their mistakes, leading economies of the world formed the General Agreement on Tariffs and Trade (GATT) after World War II to establish rules for trade and to ease trade protectionism.
“Now is not the time for the world to regress to behavior that is reminiscent of past trade errors made because of activist or populist demands,” Ford said. “It is time for nations not only to resist the rhetoric of those who are calling for unwarranted restrictions on innovation, but also to challenge those nations that bow to such pressure and place costly and trade-restrictive regulations on technologies that have been approved by scientists and regulators.”
The Council on Foreign Relations roundtable was aimed at bringing together different constituencies to discuss their interests, concerns and ideas about the resolution of current agricultural biotechnology negotiations. Joining Ford at the roundtable were CEOs from several corporations, top government officials, and leaders from non-governmental organizations.
“ASA has been committed to furthering the world’s understanding of the safety and benefits of agricultural biotechnology,” Ford said. “Biotech soybeans were first commercialized in 1996 and now make up 85 percent of the U.S. soybean crop. During the past eight years, with over $6 million in investments made by soybean producers through the soybean checkoff and the Foreign Agricultural Service, ASA has carried out biotech education for buyers, food processors, government, and consumers around the globe to protect and grow markets for U.S. soybeans.”